Teacher Retirement System of Texas’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-36,965
Closed -$59.5K 1487
2025
Q4
$59.5K Sell
36,965
-27,518
-43% -$57.6K ﹤0.01% 1608
2025
Q3
$176K Buy
+64,483
New +$215K ﹤0.01% 1912
2022
Q3
Sell
-25,737
Closed -$9K 2192
2022
Q2
$9K Sell
25,737
-7,715
-23% -$3.24K ﹤0.01% 1968
2022
Q1
$24K Buy
33,452
+1,166
+4% +$2.5K ﹤0.01% 2158
2021
Q4
$73K Buy
32,286
+8,759
+37% +$23.9K ﹤0.01% 2157
2021
Q3
$68K Buy
23,527
+6,565
+39% +$18.7K ﹤0.01% 2022
2021
Q2
$64K Buy
16,962
+2,689
+19% +$9.05K ﹤0.01% 1917
2021
Q1
$48K Buy
14,273
+2,824
+25% +$10.2K ﹤0.01% 1741
2020
Q4
$32K Buy
+11,449
New +$33.4K ﹤0.01% 1546
2018
Q1
Sell
-12,641
Closed -$188K 1946
2017
Q4
$188K Buy
+12,641
New +$210K ﹤0.01% 2112
2015
Q2
Sell
-277
Closed -$3K 2543
2015
Q1
$3K Buy
277
+1
+0.4% +$11 ﹤0.01% 2526
2014
Q4
$3K Buy
+276
New +$3.96K ﹤0.01% 2528

Other funds holding AKBA

Teacher Retirement System of Texas's AKBA Position: Q1 2026 in Review

Teacher Retirement System of Texas sold out of Akebia Therapeutics (AKBA) in Q1 2026, closing a stake of 36,965 shares — an estimated $59.5K sold.

Teacher Retirement System of Texas first reported a position in AKBA in Q4 2014 and held it in 12 quarters. The position peaked at $188K in Q4 2017. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Teacher Retirement System of Texas reported no remaining Akebia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Teacher Retirement System of Texas sold 36,965 Akebia Therapeutics shares in Q1 2026, an estimated $59.5K.
  • Teacher Retirement System of Texas first reported a position in Akebia Therapeutics in Q4 2014 and held it in 12 quarters.
  • Teacher Retirement System of Texas's Akebia Therapeutics position peaked at $188K in Q4 2017.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.